Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02401347
Title Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Melinda Telli
Indications

triple-receptor negative breast cancer

Her2-receptor negative breast cancer

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST